1.05Open3.20Pre Close81 Volume15 Open Interest14.00Strike Price1.50KTurnover127.72%IV12.72%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type-0.1755Delta0.1051Gamma63.84Leverage Ratio-0.0601Theta-0.0004Rho-11.20Eff Leverage0.0050Vega
ADMA Biologics Stock Discussion
Validating! ADMA was one of my very first picks when I started my journey in stocks. Seeing it take off and succeed based on solid fundamentals is a great boost to my self-confidence in my lebragging.
Hopefully, that doesn't sound too braggy. I'm not anything but a shitty new trader. It's important to recognize success when I have it, though. If for no other reason than to keep morale up during shitty downside weeks.
2Q 2024 Total Revenue of $107.2 Million, a 78% Increase Y-o-Y
2Q 2024 GAAP Net Income of $32.1 Million, a $38.4 Million Increase Y-o-Y
2Q 2024 Adjusted EBITDA(1) of $44.5 Million, a Nearly 600% Increase Y-o-Y
Commercial Scale Production of ADMA’s Innovative Biologics Manufacturing Process Supports a Potential Yield Enhancement of Approximately 20% from Same Start...
The tech sector, specifically semiconductors and Ai/crypto companies, aren't going anywhere. NVDA isn't going to just shrug their shoulders and give up tomorrow.
So long as you have researched and relied on financials, I think it will all come back and probably stronger than ever.
In the meantime, I've added to a couple of "defense" stocks:
$ADMA Biologics (ADMA.US)$ : 58.8% U...
by the end of the year, what price will this stock reach? Any predictions?
NEWS
IMPRESSIVE ER
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
ADMA Biologics reported impressive first quarter 2024 financial results, with a total revenue of $81.9 million, a 44% increase year-over-year. The GAAP net income was $17.8 million, a $24.6 million increase year-over-year. Adjusted EBITDA for Q1 2024 was $26.4 million, a 970% increase year-over-year. The company raised its total revenue guidance for FY 2024 to m...
No comment yet